08/14/2010 12:04 am ET | Updated May 25, 2011

Feds Broaden Big Pharma Bribery Investigation

At least a dozen major drug and device makers are under investigation by federal prosecutors and securities regulators in a broadening bribery inquiry into whether the companies made illegal payments to doctors and health officials in foreign countries.

Read more on New York Times